Last edition
News about "Australian Therapeutic Goods Administration (ATGA)"
FDA Approves Talazoparib with Enzalutamide for Prostate Cancer
The US FDA has approved talazoparib with enzalutamide for metastatic androgen pathway modulation-naïve or -sensitive prostate cancer with HRR gene mutations.
Australian Therapeutic Goods Administration (ATGA) | 03/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members